SEATTLE, — Natural Molecular Testing Corporation (Natural Molecular, NMTC), a privately-owned company providing groundbreaking clinical diagnostic molecular testing and services in the medical genomics field, announced today the launch of their laboratory developed comprehensive Personalized Medicine Panel. This cardiac panel, commercialized by Natural Molecular, is comprised of 42 targets and built using Luminex Corporation’s (NASDAQ: […]
CINCINNATI– Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that it has received FDA clearance for a new molecular diagnostic test for Mycoplasma pneumonia (M. pneumoniae), its fourth assay on the illumigene platform. This innovative test that aids in identifying an important respiratory pathogen is a strong addition to the illumigene platform. Often referred […]
Exiqon A/S (NASDAQ OMX: “EXQ”), a leading supplier of high-value products for gene expression analysis, and Asuragen, Inc. a fully integrated molecular diagnostics company focused on oncology and companion diagnostics with special capabilities in the area of miRNA, today announced the signing of a Service Center Agreement, allowing Asuragen to provide real-time PCR services based […]
Männedorf, Switzerland, – The Tecan Group (SIX Swiss Exchange: TECN) announced today that it has successfully completed the OEM development of the Dako Omnis. In May 2011, Tecan signed a major OEM agreement with Dako, an Agilent Technologies Company (NYSE: A) and worldwide provider of cancer diagnostics, for the development and supply of an advanced […]
Tokyo, – NEC Corporation (NEC; TSE: 6701) and NEC New Zealand carried out a field trial with the Institute of Environmental Science & Research Limited (ESR) to evaluate NEC’s Portable DNA Analyzer that is currently under development. This Analyzer extracts and analyzes human DNA for personal identification purposes. This evaluation of the Portable DNA Analyzer, […]
SALT LAKE CITY — BioFire Diagnostics, Inc. announced today that it obtained the CE IVD Mark under the European Directive on In Vitro Diagnostic Medical Devices for its FilmArray Blood Culture Identification (BCID) Panel. The BCID Panel tests positive blood cultures and can identify more than 100 blood pathogens known to cause sepsis. Sepsis, a […]
GERMANTOWN, Maryland, and HILDEN, Germany, – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced plans to significantly expand its existing portfolio of molecular assays used in next-generation sequencing (NGS) during 2013 as part of its expansion into this fast-growing market and ambitions to provide an ecosystem of products and services designed to drive […]
Lexington, MA, – T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the appointments of Marc Jones as Chief Financial Officer and Frédéric Sweeney, Ph.D., as Senior Director, Business Development. “Marc’s and Fred’s combined financial and business development expertise are ideal additions to the T2 Biosystems leadership team as we prepare […]
GERMANTOWN, Maryland, and HILDEN, Germany, — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that a U.S. reference laboratory customer of its HPV-related products used for cervical cancer screening has made public on June 6 a new non-exclusive agreement to consolidate the purchase of products used for women’s health diagnostics with a competitor […]
DiaGenic announces that it has made an investment in the latest technology for analyzing gene expression in blood. The deployment of QuantStudio™ Dx instruments from Life Technologies in the company’s central laboratory will further enhance the regulatory approvability and future clinical utility of DiaGenic’s products in development. DiaGenic’s diagnostic products are based on a laboratory […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
